VTGN·92840H400·US·equity·Healthcare - Biotechnology-13D/G
VTGN (VISTAGEN THERAPEUTICS INC) is held by 30 institutional investors as of Q1 2026. Largest holders: TWO SIGMA INVESTMENTS, LP ($268,387), GEODE CAPITAL MANAGEMENT, LLC ($259,170), BlackRock, Inc. ($256,322). Net institutional sentiment: Mixed.
See how VTGN's score breaks down across 4 SEC sources
Showing 1-20 of 40
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer